CB

Global Commercial Real Estate Brand SVN® Appoints New Retail Product Council Co-Chair

Retrieved on: 
Thursday, December 7, 2023
SVN, Michigan Avenue, WIRL, One Magnificent Mile, Gage Group Buildings, Willis Tower, International Council, Viacom, ICSC, KARR, CB, ABN AMRO, CREW, Commercial Real Estate Women, Transport, Shopping, CCIM, ABN, MCL

Boston, MA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- SVN International Corp. (SVN), a global commercial real estate brand, is pleased to announce the appointment of Leslie Ka rr with SVN | Commercial Advisory Group as the Co-Chair of the SVN Retail Product Council.

Key Points: 
  • Boston, MA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- SVN International Corp. (SVN), a global commercial real estate brand, is pleased to announce the appointment of Leslie Ka rr with SVN | Commercial Advisory Group as the Co-Chair of the SVN Retail Product Council.
  • Bringing over two decades of specialized experience in retail real estate, Ms. Karr’s dynamic background reflects a profound knowledge and passion for the clients she represents.
  • “The Retail Product Council is a premier venue for the creative exchange of ideas that separate SVN Retail advisors from other retail service providers.
  • Ms. Karr is an active member of Commercial Real Estate Women (CREW), Chicago Women in Retail Leasing (WIRL), and the International Council of Shopping Centers (ICSC).

Cognaize Launches “Hybrid Minds: Unlocking The Power of AI + IQ” Podcast to Explore the Convergence of AI and Human Expertise

Retrieved on: 
Wednesday, December 6, 2023
Fear, Chair, IDP, Head, McKinsey & Company, AI, Innovation, CB, Confusion, Apple Podcasts, Artificial intelligence, Intelligence, Partnership, Management

With technology evolving at an unprecedented pace, “Hybrid Minds” offers a unique exploration into the convergence of artificial intelligence and human expertise.

Key Points: 
  • With technology evolving at an unprecedented pace, “Hybrid Minds” offers a unique exploration into the convergence of artificial intelligence and human expertise.
  • Vahe Andonians, founder, chief technology officer, and chief product officer of Cognaize, dives into discussions with industry leaders and innovators that explore the new era where innovation is unbounded, driven by human ingenuity and the unknown power of AI.
  • Cognaize is designed from the ground up to address complex challenges for data scientists and deliver immediate efficiency to financial analysts.
  • Hybrid Minds is available for subscription on a number of podcast and video channels, including YouTube , Spotify , and Apple Podcasts .

ARHT Media Announces Q3 2023 Operating Results

Retrieved on: 
Wednesday, November 29, 2023
Cloud, Conference, Airport, CSA, CAPSULE, UL, TwitchCon, Amazon, Paradise, ART, CE, CB, OTCQB, NOC, Growth, Advertising, CMS

TORONTO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- ARHT Media Inc. ("ARHT" or "the Company") (TSXV:ART), (OTCQB:ARHTF) the global leader in the development, production, and distribution of high-quality, low latency hologram and digital content, today announced its financial results for the third quarter ended September 30, 2023.

Key Points: 
  • TORONTO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- ARHT Media Inc. ("ARHT" or "the Company") (TSXV:ART), (OTCQB:ARHTF) the global leader in the development, production, and distribution of high-quality, low latency hologram and digital content, today announced its financial results for the third quarter ended September 30, 2023.
  • Revenue for Q3 2023 was $1.4M compared to $2.0M for Q3 2022.
  • Gross Margin increased to 57% in Q3 2023 vs. 51% in Q3 2022.
  • In July 2023, ARHT began to roll out the ARHT 2.0 ISO software platform, the world’s most advanced holographic software platform.

Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutaneous Melanoma

Retrieved on: 
Wednesday, November 15, 2023
AJCC, Safety, OTCQB, PRN, Progression-free survival, RECIST, Patient, PFS, Pembrolizumab, CRS, CB, ORR, Metastasis, Birth control, Pension fund

KNOXVILLE, TN, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1b/2 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal sodium) in combination with standard of care immune checkpoint blockade (CB) for the treatment of advanced cutaneous melanoma ( NCT02557321 ).

Key Points: 
  • KNOXVILLE, TN, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1b/2 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal sodium) in combination with standard of care immune checkpoint blockade (CB) for the treatment of advanced cutaneous melanoma ( NCT02557321 ).
  • Initial results from CB-naïve patients in the main study cohort illustrated potential clinical benefit across all stages of metastasis.
  • Longer-term follow-up of an expanded patient population has been assessed.
  • Participants must have had at least 1 injectable lesion and at least 1 measurable target lesion and been a candidate for pembrolizumab.

RapidAI Named to the 2023 CB Insights’ Digital Health 50 List

Retrieved on: 
Tuesday, December 12, 2023
Health, Technology, Neurology, Health Technology, Artificial Intelligence, Cardiology, Cloud, Artificial intelligence, Diagnosis, Patient, FDA, Stroke, CB, Digital, Trauma, Hospital, AI, Physician, Digital health, Triage, Geographic Locator Codes, Medical imaging, Georgy Shonin

RapidAI , the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, has been named to CB Insights’ fifth-annual Digital Health 50 (formerly Digital Health 150), a list of the 50 most promising private digital health companies of 2023.

Key Points: 
  • RapidAI , the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, has been named to CB Insights’ fifth-annual Digital Health 50 (formerly Digital Health 150), a list of the 50 most promising private digital health companies of 2023.
  • RapidAI’s ability to enable efficiencies in decision making can help identify new patients, reduce time to treatment, and positively impact patient outcomes.
  • “We’re honored to be recognized for our contributions by providing an unmatched level of clinical depth across multiple disease states.”
    The 2023 CB Insights’ Digital Health 50 honorees were selected from a pool of over 10,000 companies, including applicants and nominees.
  • RapidAI was selected within the Diagnosis & Imaging category, which honored companies focused on early detection and diagnosis.

CB Financial Services, Inc. Completes Sale of Insurance Agency Subsidiary

Retrieved on: 
Friday, December 8, 2023
Banking, Professional Services, Insurance, Sale, Community Bank, Exchange, Asset purchase agreement, CB, PC, Bank, Security (finance)

CB Financial Services, Inc. (“CB”) (NASDAQGM: CBFV), the holding company of Community Bank (the “Bank”), and Exchange Underwriters, Inc. (“Exchange Underwriters”), the full-service independent insurance agency subsidiary of the Bank, announced today the completion of the sale of substantially all of the assets of Exchange Underwriters pursuant to the Asset Purchase Agreement with World Insurance Associates, LLC (“World”) for a $30.5 million cash purchase price plus possible additional revenue-based earn-out payments.

Key Points: 
  • CB Financial Services, Inc. (“CB”) (NASDAQGM: CBFV), the holding company of Community Bank (the “Bank”), and Exchange Underwriters, Inc. (“Exchange Underwriters”), the full-service independent insurance agency subsidiary of the Bank, announced today the completion of the sale of substantially all of the assets of Exchange Underwriters pursuant to the Asset Purchase Agreement with World Insurance Associates, LLC (“World”) for a $30.5 million cash purchase price plus possible additional revenue-based earn-out payments.
  • Dowling Hales acted as exclusive financial advisor and Luse Gorman, PC acted as legal counsel to CB.

BostonGene Named to the 2023 CB Insights' Digital Health 50 List

Retrieved on: 
Friday, December 8, 2023
Biotechnology, Technology, Health, General Health, Pharmaceutical, Oncology, Health Technology, Software, Artificial Intelligence, Genetics, Clinical Trials, Traction, Patient, CB Insights, CB, Digital, Cancer, Health care, Biomarker, AI, Digital health, Retail, Pharmaceutical industry, Mosaic

CB Insights named BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, to its fifth-annual Digital Health 50 showcasing the 50 most promising private digital health companies of 2023.

Key Points: 
  • CB Insights named BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, to its fifth-annual Digital Health 50 showcasing the 50 most promising private digital health companies of 2023.
  • The 50 winners, representing eight countries across the globe, were selected from a pool of over 10,000 companies.
  • "From bringing clinical trials to underserved populations to developing new drugs and therapies, this year’s Digital Health 50 winners are transforming the future of healthcare,” said Alex Lennox-Miller, CB Insights’ Lead Healthcare Analyst.
  • We are excited to follow the meaningful impact, industry-leading innovations, and continued success of this year’s winners.”
    "We are proud to have earned a place on CB Insights' Digital Health 50 list," said Andrew Feinberg, President and CEO of BostonGene.

Atropos Health Named to the 2023 CB Insights’ Digital Health 50 List

Retrieved on: 
Tuesday, December 5, 2023
Data Management, Biotechnology, Technology, Professional Services, Health, General Health, Health Technology, Research, Data Analytics, Science, Clinical Trials, Global Reach, Real, Real world data, Organization, Entrepreneurship, Synthetic media, Clinical trial, Traction, CB, Chat, Digital, Drug discovery, CB Insights, Health care, Chin Na, AI, Physician, Digital health, Pharmaceutical industry, Mosaic

CB Insights today named Atropos Health to its fifth-annual Digital Health 50 (formerly the Digital Health 150), showcasing the 50 most promising private digital health companies of 2023.

Key Points: 
  • CB Insights today named Atropos Health to its fifth-annual Digital Health 50 (formerly the Digital Health 150), showcasing the 50 most promising private digital health companies of 2023.
  • "From bringing clinical trials to underserved populations to developing new drugs and therapies, this year’s Digital Health 50 winners are transforming the future of healthcare,” said Alex Lennox-Miller, CB Insights’ Lead Healthcare Analyst.
  • Geneva OS and ChatRWD work alongside Atropos’ evidence solutions – the Green Button Informatics Consult Service, Atropos Evidence Network, and the Atropos Evidence Library.
  • Quick facts on the 2023 Digital Health 50:
    Equity funding and deals: Overall, the cohort has raised $3.2B+ over 145 equity deals since 2018.

CB Financial Services, Inc. Agrees to Sell Insurance Agency Subsidiary

Retrieved on: 
Friday, December 1, 2023
Banking, Professional Services, Insurance, Sale, Community Bank, Bank, Exchange, CB, PC, Growth, Life insurance

The transaction is subject to customary closing conditions and is anticipated to be completed in the fourth quarter of 2023.

Key Points: 
  • The transaction is subject to customary closing conditions and is anticipated to be completed in the fourth quarter of 2023.
  • Purchase price represents approximately 5.11x LTM Insurance Agency Revenue and approximately 26.08x September 30, 2023 LTM Insurance Agency Earnings.
  • John Montgomery, President and CEO of CB, stated, “The insurance business has been an integral part of Community Bank.
  • Dowling Hales acted as exclusive financial advisor and Luse Gorman, PC acted as legal counsel to CB.

MARGARET DUNNING, FINN MANAGING PARTNER, HIGHER EDUCATION, TO RETIRE

Retrieved on: 
Thursday, December 14, 2023
American Red Cross, Television, Widmeyer Wildlife Management Area, Research, STEM, Acquisition, Education, Organization, Woman, Journalism, Individual, Learning, CSR, Student, Culture, Public affairs, Marketing, Trustee, CB, University, Trinity Washington University, Federal City Council, Parent, PR, Business, Educational technology, Mass communication

NEW YORK, Dec. 14, 2023 /PRNewswire/ -- Global independent marketing and communications firm FINN Partners announced today that industry leader Margaret Dunning will retire effective Dec. 31, following four decades in communications and 10 years as managing partner of FINN's Higher Education practice.

Key Points: 
  • NEW YORK, Dec. 14, 2023 /PRNewswire/ -- Global independent marketing and communications firm FINN Partners announced today that industry leader Margaret Dunning will retire effective Dec. 31, following four decades in communications and 10 years as managing partner of FINN's Higher Education practice.
  • "Since Margaret joined the FINN Partners fold, we have worked with numerous high-caliber university and education clients.
  • Jennifer Robinson, who joined FINN in 2014 via the acquisition of gabbegroup, a boutique firm specializing in higher education, health care and philanthropy, will lead higher education work and report to Stenos.
  • With the November acquisition of C. Blohm & Associates (CB&A, A FINN Partners Company), FINN significantly expanded its work in B2B Education and EdTech.